The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 3rd 2025
Reductions of about 32% were observed during the study.
Tetraphase Submits NDA for Investigational Drug for Complicated Intra-Abdominal Infections
January 3rd 2018Tetraphase Pharmaceuticals today announced submission of its new drug application (NDA) to the FDA for eravacycline, in IV form, for the treatment of complicated intra-abdominal infections (cIAI).
Read More